Sumaylo, Nasra Astrid Q.

HRN: 21-32-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/14/2022
IVY
220mg
Q8
Pcap C , Age With Mod Dhn, G6pd
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: